Canopy Growth Corp. is worth just $13.00 a share, Echelon Wealth says

Shares of Canopy Growth Corp. (TSX:WEED) have fallen sharply in 2018, but would-be bargain hunters should continue to treat the stock with caution, Echelon Wealth Partners analyst Russell Stanley says.

On February 7, Canopy Growth Corp.announced it had completed a previously announced bought deal worth just over $200-million by selling 5.8-million shares at $34.60. The offering was underwritten by a syndicate co-led by GMP Securities LP and BMO Capital Markets, and including Canaccord Genuity Corp., Eight Capital, Beacon Securities Ltd. and PI Financial Corp.

Stanley says the financing positions the company very well to continue it aggressive expansion plan, but says even with the top of its share price recently lopped off, Canopy is a very expensive stock.

In a research update to clients Friday, Stanley maintained his “Sell” rating and one-year price target of $13.00 on Canopy Growth Corp., implying a return of negaitive 52 per cent at the time of publication.

While we continue to view WEED as worthy of a valuation premium for its industry leadership in a number of respects, the multiple implied by the current share price (60x consensus EV/C2019E EBITDA, or 56x the average of all published estimates excluding our own) is now several times the cannabis group average of 17x,” the analyst notes. “Our valuation approach for WEED (21x our estimate for C2020E EBITDA) is the most bullish valuation approach in our coverage universe, but as the implied valuation is well below the current share price, we continue to rate WEED a SELL.”

Stanley thinks Canopy will generate EBITDA of negative $17.6-million on revenue of $87.1-million in fiscal 2018. He expects those numbers will improve to EBITDA of positive $19.5-million on a topline of $278.7-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: weed
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

2 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

2 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

4 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

4 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

5 days ago